Literature DB >> 21553074

Generation of mice with a conditional Stat1 null allele.

Barbara Wallner1, Nicole R Leitner, Raimund M Vielnascher, Elisabeth Kernbauer, Thomas Kolbe, Marina Karaghiosoff, Thomas Rülicke, Thomas Decker, Mathias Müller.   

Abstract

Interferons (IFNs) are key cytokines in the innate immune response that also bridge the gap to adaptive immunity. Signaling upon stimulation by IFN type I, II and III is mediated by the Jak-Stat pathway. STAT1 is activated by all three IFN receptor complexes and absence of STAT1 from mice increases their susceptibility to pathogens. In addition, depending on the setting, STAT1 can act as tumor suppressor or oncogene. Here we report the generation and detailed functional characterization of a conditional Stat1 knockout mouse. We show the integrity of the conditional Stat1 locus and report successful in vivo deletion by means of a ubiquitous and a tissue-specific Cre recombinase. The conditional Stat1 null allele represents an important tool for identifying novel and cell-autonomous STAT1 functions in infection and cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21553074     DOI: 10.1007/s11248-011-9519-5

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  20 in total

1.  Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden.

Authors:  Peter J Klover; William J Muller; Gertraud W Robinson; Ruth M Pfeiffer; Daisuke Yamaji; Lothar Hennighausen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

Review 2.  Roles of unphosphorylated STATs in signaling.

Authors:  Jinbo Yang; George R Stark
Journal:  Cell Res       Date:  2008-04       Impact factor: 25.617

Review 3.  Conditional gene targeting.

Authors:  K Rajewsky; H Gu; R Kühn; U A Betz; W Müller; J Roes; F Schwenk
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

4.  Long-range disruption of gene expression by a selectable marker cassette.

Authors:  C T Pham; D M MacIvor; B A Hug; J W Heusel; T J Ley
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

5.  STAT1 acts as a tumor promoter for leukemia development.

Authors:  Boris Kovacic; Dagmar Stoiber; Richard Moriggl; Eva Weisz; René G Ott; Rita Kreibich; David E Levy; Hartmut Beug; Michael Freissmuth; Veronika Sexl
Journal:  Cancer Cell       Date:  2006-07       Impact factor: 31.743

6.  Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation.

Authors:  P Kovarik; D Stoiber; M Novy; T Decker
Journal:  EMBO J       Date:  1998-07-01       Impact factor: 11.598

7.  A partial form of recessive STAT1 deficiency in humans.

Authors:  Ariane Chapgier; Xiao-Fei Kong; Stéphanie Boisson-Dupuis; Emmanuelle Jouanguy; Diana Averbuch; Jacqueline Feinberg; Shen-Ying Zhang; Jacinta Bustamante; Guillaume Vogt; Julien Lejeune; Eleonore Mayola; Ludovic de Beaucoudrey; Laurent Abel; Dan Engelhard; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2009-05-11       Impact factor: 14.808

8.  Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway.

Authors:  M A Meraz; J M White; K C Sheehan; E A Bach; S J Rodig; A S Dighe; D H Kaplan; J K Riley; A C Greenlund; D Campbell; K Carver-Moore; R N DuBois; R Clark; M Aguet; R D Schreiber
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

9.  Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.

Authors:  J E Durbin; R Hackenmiller; M C Simon; D E Levy
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

10.  A time- and dose-dependent STAT1 expression system.

Authors:  Nicole R Leitner; Birgit Strobl; Marion Bokor; Ronald Painz; Thomas Kolbe; Thomas Rülicke; Mathias Müller; Marina Karaghiosoff
Journal:  BMC Biotechnol       Date:  2006-12-21       Impact factor: 2.563

View more
  17 in total

1.  The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis.

Authors:  Emma S Winkler; Swathi Shrihari; Barry L Hykes; Scott A Handley; Prabhakar S Andhey; Yan-Jang S Huang; Amanda Swain; Lindsay Droit; Kranthi K Chebrolu; Matthias Mack; Dana L Vanlandingham; Larissa B Thackray; Marina Cella; Marco Colonna; Maxim N Artyomov; Thaddeus S Stappenbeck; Michael S Diamond
Journal:  Cell       Date:  2020-07-14       Impact factor: 41.582

2.  Myeloid Cells Restrict MCMV and Drive Stress-Induced Extramedullary Hematopoiesis through STAT1.

Authors:  Riem Gawish; Tanja Bulat; Mario Biaggio; Caroline Lassnig; Zsuzsanna Bago-Horvath; Sabine Macho-Maschler; Andrea Poelzl; Natalija Simonović; Michaela Prchal-Murphy; Rita Rom; Lena Amenitsch; Luca Ferrarese; Juliana Kornhoff; Therese Lederer; Jasmin Svinka; Robert Eferl; Markus Bosmann; Ulrich Kalinke; Dagmar Stoiber; Veronika Sexl; Astrid Krmpotić; Stipan Jonjić; Mathias Müller; Birgit Strobl
Journal:  Cell Rep       Date:  2019-02-26       Impact factor: 9.423

3.  STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.

Authors:  Chrissy M Leopold Wager; Camaron R Hole; Karen L Wozniak; Michal A Olszewski; Mathias Mueller; Floyd L Wormley
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

4.  IL-27 Induces Th17 Differentiation in the Absence of STAT1 Signaling.

Authors:  Anneli Peters; Kevin D Fowler; Fanny Chalmin; Doron Merkler; Vijay K Kuchroo; Caroline Pot
Journal:  J Immunol       Date:  2015-09-25       Impact factor: 5.422

5.  Conditional ablation of TYK2 in immunity to viral infection and tumor surveillance.

Authors:  Raimund M Vielnascher; Eva Hainzl; Nicole R Leitner; Michael Rammerstorfer; David Popp; Agnieszka Witalisz; Rita Rom; Marina Karaghiosoff; Thomas Kolbe; Simone Müller; Thomas Rülicke; Caroline Lassnig; Birgit Strobl; Mathias Müller
Journal:  Transgenic Res       Date:  2014-04-03       Impact factor: 2.788

6.  Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection.

Authors:  Elisabeth Kernbauer; Verena Maier; Dagmar Stoiber; Birgit Strobl; Christine Schneckenleithner; Veronika Sexl; Ursula Reichart; Boris Reizis; Ulrich Kalinke; Amanda Jamieson; Mathias Müller; Thomas Decker
Journal:  PLoS Pathog       Date:  2012-06-14       Impact factor: 6.823

7.  Neuronal Interferon Signaling Is Required for Protection against Herpes Simplex Virus Replication and Pathogenesis.

Authors:  Pamela C Rosato; David A Leib
Journal:  PLoS Pathog       Date:  2015-07-08       Impact factor: 6.823

8.  Inducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivo.

Authors:  Nicole R Leitner; Caroline Lassnig; Rita Rom; Susanne Heider; Zsuzsanna Bago-Horvath; Robert Eferl; Simone Müller; Thomas Kolbe; Lukas Kenner; Thomas Rülicke; Birgit Strobl; Mathias Müller
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

Review 9.  Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell Types.

Authors:  Elena Tomasello; Emeline Pollet; Thien-Phong Vu Manh; Gilles Uzé; Marc Dalod
Journal:  Front Immunol       Date:  2014-10-30       Impact factor: 7.561

10.  Conserved Gammaherpesvirus Protein Kinase Counters the Antiviral Effects of Myeloid Cell-Specific STAT1 Expression To Promote the Establishment of Splenic B Cell Latency.

Authors:  P A Sylvester; C N Jondle; K P Stoltz; J Lanham; B N Dittel; V L Tarakanova
Journal:  J Virol       Date:  2021-08-10       Impact factor: 6.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.